Skip to main content
Erschienen in: Molecular Imaging and Biology 4/2020

07.02.2020 | Research Article

Assessment of Metastatic and Reactive Sentinel Lymph Nodes with B7-H3-Targeted Ultrasound Molecular Imaging: A Longitudinal Study in Mouse Models

verfasst von: Fengyang Zheng, Pan Li, Sunitha V. Bachawal, Huaijun Wang, Chaolun Li, Wei Yuan, Beijian Huang, Ramasamy Paulmurugan

Erschienen in: Molecular Imaging and Biology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore the potential of B7-H3-targeted ultrasound molecular imaging (USMI) for longitudinal assessment and differentiation of metastatic and reactive sentinel lymph nodes (SLNs) in mouse models.

Procedures

Metastatic and reactive SLN models were established by injection of 4T1 breast cancer cells and complete Freund’s adjuvant (CFA) respectively to the 4th mammary fat pad of female BALB/c mice. At day 21, 28, and 35 after inoculation, USMI was performed following intravenous injection of B7-H3-targeted microbubbles (MBB7-H3) or IgG-control microbubbles (MBcontrol). All SLNs were histopathologically examined after the last imaging session.

Results

A total of 20 SLNs from tumor-bearing mice (T-SLNs) and five SLNs from CFA-injected mice (C-SLNs) were examined by USMI. Nine T-SLNs were histopathologically positive for metastasis (MT-SLNs). From day 21 to 35, T-SLNs showed a rising trend in MBB7-H3 signal with a steep increase in MT-SLNs at day 35 (213.5 ± 80.8 a.u.) as compared to day 28 (87.6 ± 77.2 a.u., P = 0.002) and day 21 (55.7 ± 35.5 a.u., P < 0.001). At day 35, MT-SLNs had significantly higher MBB7-H3 signal than non-metastatic T-SLNs (NMT-SLNs) (101.9 ± 48.0 a.u., P = 0.001) and C-SLNs (38.5 ± 34.0 a.u., P = 0.001); MBB7-H3 signal was significantly higher than MBcontrol in MT-SLNs (P = 0.001), but not in NMT-SLNs or C-SLNs (both P > 0.05). A significant correlation was detected between MBB7-H3 signal and volume fraction of metastasis in MT-SLNs (r = 0.76, P = 0.017).

Conclusions

B7-H3-targeted USMI allows differentiation of MT-SLNs from NMT-SLNs and C-SLNs in mouse models and has great potential to evaluate tumor burden in SLNs of breast cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gradishar WJ, Anderson BO, Balassanian R et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Cancer Netw 15:433–451 Gradishar WJ, Anderson BO, Balassanian R et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Cancer Netw 15:433–451
2.
Zurück zum Zitat Banerjee M, George J, Song EY et al (2004) Tree-based model for breast cancer prognostication. J Clin Oncol 22:2567–2575PubMed Banerjee M, George J, Song EY et al (2004) Tree-based model for breast cancer prognostication. J Clin Oncol 22:2567–2575PubMed
3.
Zurück zum Zitat Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924PubMed Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924PubMed
4.
Zurück zum Zitat Fisher B, Bauer M, Wickerham DL et al (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52:1551–1557PubMed Fisher B, Bauer M, Wickerham DL et al (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52:1551–1557PubMed
5.
Zurück zum Zitat Soares EWS, Nagai HM, Bredt LC et al (2014) Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients. World J Surg Oncol 12:67PubMedPubMedCentral Soares EWS, Nagai HM, Bredt LC et al (2014) Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients. World J Surg Oncol 12:67PubMedPubMedCentral
6.
Zurück zum Zitat Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663PubMed Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663PubMed
7.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553PubMed Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553PubMed
8.
Zurück zum Zitat Ashikaga T, Krag DN, Land SR et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111–118PubMedPubMedCentral Ashikaga T, Krag DN, Land SR et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111–118PubMedPubMedCentral
9.
Zurück zum Zitat Montgomery LL, Thorne AC, Van Zee KJ et al (2002) Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 95:385–388 table of contentsPubMed Montgomery LL, Thorne AC, Van Zee KJ et al (2002) Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 95:385–388 table of contentsPubMed
10.
Zurück zum Zitat Pesek S, Ashikaga T, Krag LE, Krag D (2012) The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg 36:2239–2251PubMedPubMedCentral Pesek S, Ashikaga T, Krag LE, Krag D (2012) The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg 36:2239–2251PubMedPubMedCentral
11.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888PubMed Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888PubMed
12.
Zurück zum Zitat Esen G, Gurses B, Yilmaz MH et al (2005) Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes. Eur Radiol 15:1215–1223PubMed Esen G, Gurses B, Yilmaz MH et al (2005) Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes. Eur Radiol 15:1215–1223PubMed
13.
Zurück zum Zitat Esen G (2006) Ultrasound of superficial lymph nodes. Eur J Radiol 58:345–359PubMed Esen G (2006) Ultrasound of superficial lymph nodes. Eur J Radiol 58:345–359PubMed
14.
Zurück zum Zitat Alvarez S, Añorbe E, Alcorta P et al (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol 186:1342–1348PubMed Alvarez S, Añorbe E, Alcorta P et al (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol 186:1342–1348PubMed
15.
Zurück zum Zitat Mori N, Mugikura S, Miyashita M et al (2018) Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer. Jpn J Radiol 37:145–153 Mori N, Mugikura S, Miyashita M et al (2018) Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer. Jpn J Radiol 37:145–153
16.
Zurück zum Zitat Zhao J, Zhang J, Zhu QL et al (2018) The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: a prospective study. Eur Radiol 28:1654–1661PubMed Zhao J, Zhang J, Zhu QL et al (2018) The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: a prospective study. Eur Radiol 28:1654–1661PubMed
17.
Zurück zum Zitat Goldberg BB, Merton DA, Liu J-B et al (2004) Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 230:727–734PubMed Goldberg BB, Merton DA, Liu J-B et al (2004) Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 230:727–734PubMed
18.
Zurück zum Zitat Wang Y, Cheng Z, Li J, Tang J (2010) Gray-scale contrast-enhanced ultrasonography in detecting sentinel lymph nodes: an animal study. Eur J Radiol 74:e55–e59PubMed Wang Y, Cheng Z, Li J, Tang J (2010) Gray-scale contrast-enhanced ultrasonography in detecting sentinel lymph nodes: an animal study. Eur J Radiol 74:e55–e59PubMed
19.
Zurück zum Zitat Goldberg BB, Merton DA, Bin LJ et al (2011) Contrast-enhanced ultrasound imaging of sentinel lymph nodes after peritumoral administration of sonazoid in a melanoma tumor animal model. J Ultrasound Med 30:441–453PubMed Goldberg BB, Merton DA, Bin LJ et al (2011) Contrast-enhanced ultrasound imaging of sentinel lymph nodes after peritumoral administration of sonazoid in a melanoma tumor animal model. J Ultrasound Med 30:441–453PubMed
20.
Zurück zum Zitat Poanta L, Serban O, Pascu I et al (2014) The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study. Med Ultrason 16:7–14PubMed Poanta L, Serban O, Pascu I et al (2014) The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study. Med Ultrason 16:7–14PubMed
21.
Zurück zum Zitat Slaisova R, Benda K, Jarkovsky J et al (2013) Contrast-enhanced ultrasonography compared to gray-scale and power doppler in the diagnosis of peripheral lymphadenopathy. Eur J Radiol 82:693–698PubMed Slaisova R, Benda K, Jarkovsky J et al (2013) Contrast-enhanced ultrasonography compared to gray-scale and power doppler in the diagnosis of peripheral lymphadenopathy. Eur J Radiol 82:693–698PubMed
22.
Zurück zum Zitat Hong YR, Luo ZY, Mo GQ et al (2017) Role of contrast-enhanced ultrasound in the pre-operative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma. Ultrasound Med Biol 43:2567–2575PubMed Hong YR, Luo ZY, Mo GQ et al (2017) Role of contrast-enhanced ultrasound in the pre-operative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma. Ultrasound Med Biol 43:2567–2575PubMed
23.
Zurück zum Zitat Rubaltelli L, Corradin S, Dorigo A et al (2007) Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography. Am J Roentgenol 188:977–983 Rubaltelli L, Corradin S, Dorigo A et al (2007) Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography. Am J Roentgenol 188:977–983
24.
Zurück zum Zitat Kiessling F, Bzyl J, Fokong S et al (2012) Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics. Curr Pharm Des 18:2184–2199PubMed Kiessling F, Bzyl J, Fokong S et al (2012) Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics. Curr Pharm Des 18:2184–2199PubMed
25.
Zurück zum Zitat Abou-Elkacem L, Bachawal SV, Willmann JK (2015) Ultrasound molecular imaging: moving toward clinical translation. Eur J Radiol 84:1685–1693PubMedPubMedCentral Abou-Elkacem L, Bachawal SV, Willmann JK (2015) Ultrasound molecular imaging: moving toward clinical translation. Eur J Radiol 84:1685–1693PubMedPubMedCentral
26.
Zurück zum Zitat Kiessling F, Fokong S, Bzyl J et al (2014) Recent advances in molecular, multimodal and theranostic ultrasound imaging. Adv Drug Deliv Rev 72:15–27PubMed Kiessling F, Fokong S, Bzyl J et al (2014) Recent advances in molecular, multimodal and theranostic ultrasound imaging. Adv Drug Deliv Rev 72:15–27PubMed
27.
Zurück zum Zitat Seaman S, Stevens J, Yang MY et al (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11:539–554PubMedPubMedCentral Seaman S, Stevens J, Yang MY et al (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11:539–554PubMedPubMedCentral
28.
Zurück zum Zitat Bachawal SV, Jensen KC, Wilson KE et al (2015) Breast cancer detection by B7-H3-targeted ultrasound molecular imaging. Cancer Res 75:2501–2509PubMedPubMedCentral Bachawal SV, Jensen KC, Wilson KE et al (2015) Breast cancer detection by B7-H3-targeted ultrasound molecular imaging. Cancer Res 75:2501–2509PubMedPubMedCentral
29.
Zurück zum Zitat Turtoi A, Dumont B, Greffe Y et al (2011) Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. J Proteome Res 10:3160–3182PubMed Turtoi A, Dumont B, Greffe Y et al (2011) Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. J Proteome Res 10:3160–3182PubMed
30.
Zurück zum Zitat Arigami T, Narita N, Mizuno R et al (2010) B7-H3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg 252:1044–1051PubMed Arigami T, Narita N, Mizuno R et al (2010) B7-H3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg 252:1044–1051PubMed
31.
Zurück zum Zitat Liu C, Liu J, Wang J et al (2013) B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Mol Med Rep 7:134–138PubMed Liu C, Liu J, Wang J et al (2013) B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Mol Med Rep 7:134–138PubMed
32.
Zurück zum Zitat Nam K, Stanczak M, Forsberg F et al (2018) Sentinel lymph node characterization with a dual-targeted molecular ultrasound contrast agent. Mol Imaging Biol 20:221–229PubMedPubMedCentral Nam K, Stanczak M, Forsberg F et al (2018) Sentinel lymph node characterization with a dual-targeted molecular ultrasound contrast agent. Mol Imaging Biol 20:221–229PubMedPubMedCentral
33.
Zurück zum Zitat Weiss LM, O’Malley D (2013) Benign lymphadenopathies. Mod Pathol 26(Suppl 1):S88–S96 Weiss LM, O’Malley D (2013) Benign lymphadenopathies. Mod Pathol 26(Suppl 1):S88–S96
34.
Zurück zum Zitat Lei J, Xue HD, Li Z et al (2010) Possible pathological basis for false diagnoses of lymph nodes by USPIO-enhanced MRI in rabbits. J Magn Reson Imaging 31:1428–1434PubMed Lei J, Xue HD, Li Z et al (2010) Possible pathological basis for false diagnoses of lymph nodes by USPIO-enhanced MRI in rabbits. J Magn Reson Imaging 31:1428–1434PubMed
36.
Zurück zum Zitat Tafreshi NK, Enkemann SA, Bui MM et al (2011) A mammaglobin-a targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes. Cancer Res 71:1050–1059PubMed Tafreshi NK, Enkemann SA, Bui MM et al (2011) A mammaglobin-a targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes. Cancer Res 71:1050–1059PubMed
37.
Zurück zum Zitat Willmann JK, Paulmurugan R, Chen K et al (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246:508–518PubMedPubMedCentral Willmann JK, Paulmurugan R, Chen K et al (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246:508–518PubMedPubMedCentral
38.
Zurück zum Zitat Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689PubMed Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689PubMed
39.
Zurück zum Zitat Jin X, Liang N, Wang M et al (2016) Integrin imaging with 99mTc-3PRGD2 SPECT/CT shows high specificity in the diagnosis of lymph node metastasis from non-small cell lung cancer. Radiology 281:958–966PubMed Jin X, Liang N, Wang M et al (2016) Integrin imaging with 99mTc-3PRGD2 SPECT/CT shows high specificity in the diagnosis of lymph node metastasis from non-small cell lung cancer. Radiology 281:958–966PubMed
40.
Zurück zum Zitat Teicher BA (2006) Tumor models for efficacy determination. Mol Cancer Ther 5:2435–2443PubMed Teicher BA (2006) Tumor models for efficacy determination. Mol Cancer Ther 5:2435–2443PubMed
41.
Zurück zum Zitat Miller F, Care A (2000) Mouse 4T1 breast tumor model. Curr Protoc Immunol 20:1–16 Miller F, Care A (2000) Mouse 4T1 breast tumor model. Curr Protoc Immunol 20:1–16
42.
Zurück zum Zitat Taub RN, Krantz AR, Dresser DW (1970) The effect of localized injection of adjuvant material on the draining lymph node. I Histology. Immunology 18:171–186PubMedPubMedCentral Taub RN, Krantz AR, Dresser DW (1970) The effect of localized injection of adjuvant material on the draining lymph node. I Histology. Immunology 18:171–186PubMedPubMedCentral
43.
Zurück zum Zitat Krzystyniak K, Kozlowska E, Desjardins R et al (1995) Different T-cell activation by streptozotocin and Freund’s adjuvant in popliteal lymph node (PLN). Int J Immunopharmacol 17:189–196PubMed Krzystyniak K, Kozlowska E, Desjardins R et al (1995) Different T-cell activation by streptozotocin and Freund’s adjuvant in popliteal lymph node (PLN). Int J Immunopharmacol 17:189–196PubMed
44.
Zurück zum Zitat Jiménez-González M, Plaza-García S, Arizeta J et al (2017) A longitudinal MRI study on lymph nodes histiocytosis of a xenograft cancer model. PLoS One 12:1–16 Jiménez-González M, Plaza-García S, Arizeta J et al (2017) A longitudinal MRI study on lymph nodes histiocytosis of a xenograft cancer model. PLoS One 12:1–16
45.
Zurück zum Zitat Herman PG, Kim CS, de Sousa MA, Mellins HZ (1976) Microcirculation of the lymph node with metastases. Am J Pathol 85:333–348PubMedPubMedCentral Herman PG, Kim CS, de Sousa MA, Mellins HZ (1976) Microcirculation of the lymph node with metastases. Am J Pathol 85:333–348PubMedPubMedCentral
46.
Zurück zum Zitat Li C, Torres VC, Tichauer KM (2018) Noninvasive detection of cancer spread to lymph nodes: a review of molecular imaging principles and protocols. J Surg Oncol 118:301–314PubMed Li C, Torres VC, Tichauer KM (2018) Noninvasive detection of cancer spread to lymph nodes: a review of molecular imaging principles and protocols. J Surg Oncol 118:301–314PubMed
47.
Zurück zum Zitat Li G, Quan Y, Che F, Wang L (2018) B7-H3 in tumors: friend or foe for tumor immunity? Cancer Chemother Pharmacol 81:245–253PubMed Li G, Quan Y, Che F, Wang L (2018) B7-H3 in tumors: friend or foe for tumor immunity? Cancer Chemother Pharmacol 81:245–253PubMed
48.
Zurück zum Zitat Sun J, Guo Y-D, Li X-N et al (2014) B7-H3 expression in breast cancer and upregulation of VEGF through gene silence. Onco Targets Ther 7:1979–1986PubMedPubMedCentral Sun J, Guo Y-D, Li X-N et al (2014) B7-H3 expression in breast cancer and upregulation of VEGF through gene silence. Onco Targets Ther 7:1979–1986PubMedPubMedCentral
49.
Zurück zum Zitat Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis. JAMA 318:918PubMedPubMedCentral Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis. JAMA 318:918PubMedPubMedCentral
50.
Zurück zum Zitat Kramer K, Kushner BH, Modak S et al (2010) Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma. J Neuro-Oncol 97:409–418 Kramer K, Kushner BH, Modak S et al (2010) Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma. J Neuro-Oncol 97:409–418
51.
Zurück zum Zitat Loos M, Hedderich DM, Friess H, Kleeff J (2010) B7-h3 and its role in antitumor immunity. Clin Dev Immunol 2010:683875PubMedPubMedCentral Loos M, Hedderich DM, Friess H, Kleeff J (2010) B7-h3 and its role in antitumor immunity. Clin Dev Immunol 2010:683875PubMedPubMedCentral
Metadaten
Titel
Assessment of Metastatic and Reactive Sentinel Lymph Nodes with B7-H3-Targeted Ultrasound Molecular Imaging: A Longitudinal Study in Mouse Models
verfasst von
Fengyang Zheng
Pan Li
Sunitha V. Bachawal
Huaijun Wang
Chaolun Li
Wei Yuan
Beijian Huang
Ramasamy Paulmurugan
Publikationsdatum
07.02.2020
Verlag
Springer International Publishing
Erschienen in
Molecular Imaging and Biology / Ausgabe 4/2020
Print ISSN: 1536-1632
Elektronische ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-020-01478-9

Weitere Artikel der Ausgabe 4/2020

Molecular Imaging and Biology 4/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.